We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...

2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound ® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label ...

Eli Lilly will now sell cheaper vials of Zepbound, presenting a direct challenge to telehealth companies that offer compounded versions of the medication. By Dani Blum With high demand for drugs ...

Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could ... LillyDirect not only makes for a “transparent price” by removing ...

Eli Lilly (NYSE:LLY) slashed the prices of the two lowest doses of its blockbuster weight loss medication Zepbound on Tuesday for purchases on its telehealth platform, LillyDirect. Accordingly, a ...

Eli Lilly and Co. said Tuesday it is now selling ... with an on-label prescription can buy single-dose vials, a move the company said will expand access and supply. The company said 2.5-milligram ...

Eli Lilly and Company (NYSE:LLY) was a part of 100 hedge fund portfolios at the end of Q2 2024, down from 109 in the previous ...

The company’s financial health is underscored by a 90% increase in operating income, primarily due to higher revenue from new products (Gordon Brooks, Interim CFO). Additionally, Eli Lilly is ...

We recently compiled a list titled Starter Stock Portfolio: 10 Safe Stocks To Invest In Now. In this article, we are going to ...

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to the career path of his predecessor, Anat Ashkenazi, who also spent two ...

In a report released today, Peter Verdult from Citi initiated coverage with a Buy rating on Eli Lilly & Co (LLY – Research Report) and a price target of $1,060.00. The company’s shares closed ...